Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2013
10/30/2013EP2655404A1 Novel alkali-resistant variants of protein a and their use in affinity chromatography
10/30/2013EP2655402A1 Oprf/i agents and their use in hospitalized and other patients
10/30/2013EP2654790A1 Modified antibody with improved half-life
10/30/2013EP2654789A1 Antibodies against human cd39 and use thereof
10/30/2013EP2654784A2 Stable immunogenic compositions of staphylococcus aureus antigens
10/30/2013CN1922199B CA6 antigen-specific cytotoxic conjugate and methods of using same
10/30/2013CN103380145A Human anti-SOD1 antibodies
10/30/2013CN103380144A Isoform enriched antibody preparation and method for obtaining it
10/30/2013CN103380143A Fibronectin based scaffold domain proteins that bind IL-23
10/30/2013CN103376325A Application of angiotensinogen protein precursor as obesity-diabetes marker
10/30/2013CN103376323A Application of apolipoprotein C-III as marker of obesity-diabetes
10/30/2013CN103374576A Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them
10/30/2013CN103374552A PHF 8 (Plant Homedomain Finger Protein 8) protein fragment as well as prokaryotic expression and purification method and antibody thereof
10/30/2013CN103374074A Anti-CD25 single-chain antibody
10/30/2013CN103374073A Human derived monoclonal antibody for identifying activated integrin alpha 4 beta 7
10/30/2013CN103374072A Preparation of anti-Mac-2BP humanized antibody
10/30/2013CN103374071A Preparation of anti-DERLIN-1 humanized antibody
10/30/2013CN103374070A Anti-rabies-virus combination molecule 2F5
10/30/2013CN103374069A Anti-rabies-virus combination molecule 2E1
10/30/2013CN103374068A Preparation method and application of novel monoclonal antibody
10/30/2013CN103374048A Streptomycin hapten, as well as preparation method and application thereof
10/30/2013CN103372209A Application of antibody of gp96 protein in preparation of cancer cell inhibitor
10/30/2013CN102924600B Death receptor-5 agitated polyvalent antibody and application thereof in preparation of anti-tumor medicines
10/30/2013CN102827076B Universal hapten of fluoroquinolone medicines, artificial antigen, broad-spectrum monoclonal antibody, preparation method and application
10/30/2013CN102671637B Biomimetic specific immune adsorption material with PAMAM (Polyamidoamine) as spacer arm, and preparation method and application thereof
10/30/2013CN102618502B Hybridoma cell strain capable of secreting monoclonal antibodies to quinolones and application of monoclonal antibodies thereof
10/30/2013CN102603892B Tumor marker FOXP3 auto-antibody and application thereof
10/30/2013CN102533664B Hybridoma cell strain excreting monoclonal antibody (MAb) resisting rice blackstreaked dwarf virus (RBSDV) and application of MAb
10/30/2013CN102532310B Monoclonal antibody against grass carp reovirus VP5 protein and application of monoclonal antibody
10/30/2013CN102516390B Preparation of multi-epitope TK-1 antibody, and application of multi-epitope TK-1 antibody in evaluating treatment effect on tumor patient
10/30/2013CN102504027B Preparation of multi-epitope thymidine kinase 1 (TK1) antibody and use of multi-epitope TK1 antibody for early tumor detection and risk early warning in mass physical examination screening
10/30/2013CN102492037B High affinity fusarium specific single-chain antibody and preparation method thereof
10/30/2013CN102464716B ELISA (Enzyme-Linked Immuno Sorbent Assay) kit for detecting Japanese encephalitis virus antigens in swine, human and mosquitoes and application
10/30/2013CN102453093B Screening and application of single-chain antibody against fumonisin
10/30/2013CN102453092B Screening on single chain antibody for resisting fusarium and application thereof
10/30/2013CN102432683B Preparation of multi-epitope TK1 antibody and application of multi-epitope TK1 antibody to evaluation on recurrence risk and prognosis of tumor patient at early stage
10/30/2013CN102297968B Kit for assisted diagnosis of tuberculosis
10/30/2013CN102219853B Anti-H5N1 type bird flue virus vicuna VHH heavy chain antibody as well as preparation method and application thereof
10/30/2013CN102112154B IL-1alpha abs and methods of use
10/30/2013CN101687927B Antibody directed to G protein coupled receptors (GPCR)
10/30/2013CN101641374B Binding members for interleukin-6
10/30/2013CN101516912B Antibodies recognizing carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
10/30/2013CN101501072B Antibody molecules which bind human IL-17
10/30/2013CN101280010B Shrimp allergen antishrimp allergen antibody and use thereof
10/30/2013CN101044242B Tumor specific antibody
10/29/2013US8569464 Purification of proteins
10/29/2013US8569463 Method of covalently modifying proteins with organic molecules to prevent aggregation
10/29/2013US8569462 Antibodies specific for TGF-beta and methods for treating thereof
10/29/2013US8569461 Humanized anti-interleukin 3 receptor alpha chain antibodies
10/29/2013US8569459 Targeted binding agents directed to sonic hedgehog homolog and uses thereof
10/29/2013US8569456 Receptor activator of NF-kappaB
10/29/2013US8569448 NMDAR biomarkers for diagnosis and treatment of traumatic brain injury and other disorders
10/29/2013US8569242 Method of treating degenerative disorders of the nervous system
10/29/2013US8569241 Composition for improving brain function and method for improving brain function
10/29/2013US8569238 Plasma protein effective for suppressing cough
10/29/2013US8569230 Antimicrobial kinocidin compositions and methods of use
10/29/2013US8569005 Chloroacetamidine based inhibitors and activity based probes for the protein arginine methytransferases
10/29/2013US8568990 Methods for identifying compounds that modulate sensory signaling through the taste cell specific G-protein coupled receptor GPCR-B4
10/29/2013US8568731 Staphylococcus aureus antigenic polypeptides and compositions
10/29/2013US8568729 Anthracycline-antibody conjugates for cancer therapy
10/29/2013US8568727 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
10/29/2013US8568725 Method of treating transplant rejection with an anti-CD40 antibody
10/29/2013US8568698 Methods and materials for providing teeth with a white appearance
10/29/2013CA2589471C Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84
10/29/2013CA2550551C Fusion polypeptides capable of activating receptors
10/29/2013CA2546619C Il-23 and its receptor; related reagents and methods
10/29/2013CA2535515C Cd20-binding polypeptide compositions
10/29/2013CA2509136C Human il-1 beta antagonists
10/29/2013CA2466128C Antibodies to cd40
10/29/2013CA2453100C Novel human hepatoma lines, methods for obtaining same and uses thereof
10/29/2013CA2442363C Reducing the immunogenicity of fusion proteins
10/29/2013CA2435672C Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/29/2013CA2371794C Human antibiotic proteins
10/24/2013WO2013158577A1 Anti-baff-anti-il-17 bispecific antibodies
10/24/2013WO2013158279A1 Protein purification methods to reduce acidic species
10/24/2013WO2013158276A1 Antibody binding microbial heparin binding motif to retard or prevent microbial biofilm formation on implanted medical devices
10/24/2013WO2013158275A1 Cell culture methods to reduce acidic species
10/24/2013WO2013158274A1 ANTI-MIGE ANTIBODIES THAT BIND TO THE JUNCTION BETWEEN CH4 AND CεMX DOMAINS
10/24/2013WO2013158273A1 Methods to modulate c-terminal lysine variant distribution
10/24/2013WO2013157954A1 Methods and means for the production of ig-like molecules
10/24/2013WO2013157953A1 Methods and means for the production of ig-like molecules
10/24/2013WO2013157105A1 Mucin 5ac specific human antibody and use thereof
10/24/2013WO2013157102A1 Mucin 5ac specific human antibody and use thereof
10/24/2013WO2013156534A1 Cross-reactive staphylococcus aureus antibody
10/24/2013WO2013156473A1 Combination therapy of anti-mif antibodies and chemotherapeutics
10/24/2013WO2013156472A1 Combination therapy of anti-mif antibodies and glucocorticoids
10/24/2013WO2013156148A1 THE IgM AND IgE HEAVY CHAIN DOMAIN 2 AS COVALENTLY LINKED HOMODIMERIZATION MODULES FOR THE GENERATION OF FUSION PROTEINS WITH DUAL SPECIFICITY
10/24/2013WO2013156054A1 The igm and ige heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificity
10/24/2013WO2013155883A1 Hybridoma cell line 3g1 and monoclonal antibody produced thereby against aflatoxin b1
10/24/2013WO2013155882A1 Hybridoma cell line 10g4 and monoclonal antibody produced thereby against sum of aflatoxins b1, b2, g1, and g2
10/24/2013WO2013101972A3 Dual variable domain immunoglobulins and uses thereof
10/24/2013WO2013085550A3 V1v2 immunogens
10/24/2013WO2012141554A8 Complex in which anti-cotinine antibody is bound to conjugate of cotinine and binding substance, and use thereof
10/24/2013WO2008083493A8 Stabilization of cyclic peptide structures
10/24/2013WO2002079385A9 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/24/2013WO2002059275A9 39362, a novel human cub domain-containing protein family member and uses thereof
10/24/2013US20130281922 Antibodies against ror1 and uses thereof
10/24/2013US20130281677 Modified antibody with improved half-life
10/24/2013US20130281676 Antibodies to matrix metalloproteinase 9
10/24/2013US20130281675 Antibodies to matrix metalloproteinase 9
1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 1494